debrisoquin has been researched along with Amentia in 1 studies
Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hubble, JP | 1 |
Kurth, JH | 1 |
Glatt, SL | 1 |
Kurth, MC | 1 |
Schellenberg, GD | 1 |
Hassanein, RE | 1 |
Lieberman, A | 1 |
Koller, WC | 1 |
1 other study available for debrisoquin and Amentia
Article | Year |
---|---|
Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia.
Topics: Aged; Apolipoproteins; Case-Control Studies; Comorbidity; Debrisoquin; Dementia; Environmental Expos | 1998 |